您的位置: 首页 > 农业专利 > 详情页

Antibodies against TL1a and uses thereof
专利权人:
Teva Pharmaceuticals Australia Pty Ltd.
发明人:
Poulton, Lynn Dorothy,Clarke, Adam,Pow, Andrew James,Tamvakis, Debra,Kopsidas, George,Doyle, Anthony Gerard,Jennings, Philip Anthony,Pollard, Matthew
申请号:
AU2012315474
公开号:
AU2012315474A1
申请日:
2012.09.28
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present disclosure provides TNF-like ligand 1a (TL1a)-binding proteins comprising an antigen binding domain of an antibody which binds specifically to TL1a and inhibits interaction of TL1a and Death Receptor 3 (DR3) and which does not inhibit the interaction of TL1a and Decoy Receptor 3 (DcR3). The present disclosure also provides uses of the TL1a-binding proteins.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充